4882.T
Perseus Proteomics Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 141.00
−0.70%Margins
Gross margin
74.3%
EBITDA margin
-588.0%
EBIT margin
-549.3%
Net margin
-540.7%
FCF margin
-567.3%
-85.6%
Return on equity
-57.3%
Return on assets
-87.0%
Return on invested capital
0.10x
Asset turnover
-JPY 719.0M
Cash from operations
JPY 84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026